Choroidal Neovascularization
📧 Sign up to get email alerts when something new happens for Choroidal Neovascularization.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) [Phase 2, Phase 3]
EyeBiotech's MK-8748 (EYE201) is in a Phase 2/3 trial for macular degeneration, including age-related macular degeneration, with recruitment…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) [Phase 2, Phase 3]
Phase 2/3 trial MK-8748 (EYE201) for age-related macular degeneration is described in this update. The study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD [Phase 3]
Phase 3 pivotal study update on RGX-314 gene therapy for neovascular age-related macular degeneration (nAMD), with recruitment ongoing under…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Impact of Non-Exudative Type 1 MNV on AMD Progression
This University of Utah–sponsored trial investigates whether non-exudative type 1 macular neovascularization influences the progression of a…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Effect of Video Viewing on Intravitreal Injection Experience [NA]
A recruiting clinical trial studying whether video viewing during intravitreal injections improves patient experience in age-related macular…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Biomarkers and Choroidal Neovascularization
This entry describes an INSERM-led clinical trial in France investigating biomarkers for Choroidal Neovascularization and Mineralocorticoid …
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
A protocol for an interpretable fundus disease report generator using weakly labeled data, sponsored by Zhongshan Ophthalmic Center, Sun Yat…
-
CLINICAL_TRIALS research · 2017-03-01Clinical Trial Update: Observation of Treatment Patterns With Lucentis in Approved Indications
An observational study examining how Lucentis is used in approved indications such as neovascular age-related macular degeneration and diabe…
-
CLINICAL_TRIALS research · 2015-09-18Clinical Trial Update: Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
A completed genetic analysis study investigating chronic central serous chorioretinopathy that masquerades as neovascular age-related macula…
-
CLINICAL_TRIALS research · 2014-06-04Clinical Trial Update: A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV [Phase 3]
Phase 3 randomized, double-blind, multicenter, sham-controlled study assessing the safety and efficacy of Conbercept in patients with myopic…
-
CLINICAL_TRIALS research · 2012-02-13Clinical Trial Update: A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye [NA]
A clinical trial update investigating the effects of repeated intravitreal injections on bacteria around the eye, with conditions including …
-
CLINICAL_TRIALS research · 2007-12-05Clinical Trial Update: Stratus Versus Cirrus OCT in AMD
Clinical trial update comparing Stratus versus Cirrus OCT devices for age-related macular degeneration and choroidal neovascularization.
-
CLINICAL_TRIALS research · 2006-10-23Clinical Trial Update: Avastin for CNV Secondary to Pattern Dystrophy [Phase 2, Phase 3]
This update reports on ongoing Phase 2/Phase 3 trials evaluating Avastin (bevacizumab) for choroidal neovascularization secondary to pattern…